Literature DB >> 28558865

Early Onset of Sleep-Disordered Breathing in Two Children With SEPN1-Related Myopathies.

Mathilde Viprey1,2, Ha Trang3, Michaël Pomedio1, Katia Bessaci-Kabouya1, Pascal Sabouraud1, Fawzia Cheliout-Heraut3, Pierre Mauran1,2.   

Abstract

ABSTRACT: Selenoprotein-related myopathy (SEPN1-RM) is a rare disease with a variable clinical presentation. The selenoprotein N1 gene (SEPN1) mutation causing this congenital muscular dystrophy was identified in 2001. Sleep-disordered breathing (SDB) may occur in young patients with SEPN1-RM who are still able to walk. We report the cases of two children with SEPN1-RM who presented with SDB at the ages of 7 and 12 years and for whom long-term nocturnal noninvasive ventilation yielded significant improvement. Based on literature review and our current cases, it seems that there is no obvious relationship between the time since SDB onset and outcome of pulmonary function tests or limb muscle weakness. We therefore suggest that SDB should be systematically screened for in patients with SEPN1-RM, at regular intervals using nocturnal polysomnography.
© 2017 American Academy of Sleep Medicine

Entities:  

Keywords:  congenital muscular dystrophy; noninvasive ventilation; polysomnography; respiratory insufficiency; selenoprotein; selenoprotein N1-related myopathies; sleep apnea syndrome; sleep-disordered breathing

Mesh:

Substances:

Year:  2017        PMID: 28558865      PMCID: PMC5566467          DOI: 10.5664/jcsm.6734

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  7 in total

Review 1.  Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report.

Authors: 
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

2.  Sleep, sleep disordered breathing, and nocturnal hypoventilation in children with neuromuscular diseases.

Authors:  Raanan Arens; Hiren Muzumdar
Journal:  Paediatr Respir Rev       Date:  2010-03       Impact factor: 2.726

3.  Sleep-disordered breathing in children with thoracic insufficiency syndrome.

Authors:  Amanda Striegl; Maida L Chen; Yemiserach Kifle; Kit Song; Gregory Redding
Journal:  Pediatr Pulmonol       Date:  2010-05

4.  Selenoprotein N deficiency in mice is associated with abnormal lung development.

Authors:  Behzad Moghadaszadeh; Branden E Rider; Michael W Lawlor; Martin K Childers; Robert W Grange; Kushagra Gupta; Steve S Boukedes; Caroline A Owen; Alan H Beggs
Journal:  FASEB J       Date:  2013-01-16       Impact factor: 5.191

5.  The phenotype and long-term follow-up in 11 patients with juvenile selenoprotein N1-related myopathy.

Authors:  Ulrike Schara; Wolfram Kress; Carsten G Bönnemann; Nico Breitbach-Faller; Christoph G Korenke; Gudrun Schreiber; Mechthild Stoetter; Ana Ferreiro; Maja von der Hagen
Journal:  Eur J Paediatr Neurol       Date:  2007-10-22       Impact factor: 3.140

Review 6.  Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management.

Authors:  Athanasios G Kaditis; Maria Luz Alonso Alvarez; An Boudewyns; Emmanouel I Alexopoulos; Refika Ersu; Koen Joosten; Helena Larramona; Silvia Miano; Indra Narang; Ha Trang; Marina Tsaoussoglou; Nele Vandenbussche; Maria Pia Villa; Dick Van Waardenburg; Silke Weber; Stijn Verhulst
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

7.  SEPN1-related myopathies: clinical course in a large cohort of patients.

Authors:  M Scoto; S Cirak; R Mein; L Feng; A Y Manzur; S Robb; A-M Childs; R M Quinlivan; H Roper; D H Jones; C Longman; G Chow; M Pane; M Main; M G Hanna; K Bushby; C Sewry; S Abbs; E Mercuri; F Muntoni
Journal:  Neurology       Date:  2011-06-14       Impact factor: 9.910

  7 in total
  1 in total

1.  SEPN1-Related Myopathy: The Importance of Diagnosis and Challenges to Management of CMD in Resource Poor Settings.

Authors:  Siddhartha Gajam; Madhuri Maganthi; Ann Agnes Mathew; Suman Rath
Journal:  Ann Indian Acad Neurol       Date:  2021-03-05       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.